FOXK1 and central nervous system cancer: This study first examined the endogenous expression of ZRANB2, SNHG20 and FOXK1 in glioma tissues and U87 and U251 glioma cells, and studied the effects of ZRANB2, SNHG20 and FOXK1 on VM formation in glioma.